Related Experiment Video
Updated: Apr 28, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
[Innovation and the next generation radiotherapy system]
Abstract:
Innovation is the key to future success for Japan that is slowly falling behind. Industries targeted by the "Abenomics" growth strategy include healthcare and medicine. Since cancer is the leading cause of death in Japan, the development of a system that can detect and treat early stage cancers will be very valuable for patient QOL and reducing health care costs. Although the effectiveness of radiation therapy for treating early stage cancer is widely recognized, there has been no system to treat small, moving tumors with sub millimeter accuracy. A project supported by NEDO develops a "Next-Generation Radiation Therapy System" that uses high energy, narrow X-rays beams that can be accurately pinpointed deep inside the body. Performance testing of a prototype system is currently underway at the National Center for Global Health and Medicine in Tokyo.
Insights
Japan is developing a next-generation radiation therapy system to precisely treat small, moving tumors. This innovation aims to improve early-stage cancer treatment, enhance patient quality of life, and reduce healthcare costs.
Area of Science:
- Oncology
- Medical Physics
- Biomedical Engineering
Context:
- Japan faces challenges in healthcare innovation, with cancer as a leading cause of death.
- The Abenomics growth strategy prioritizes healthcare and medicine.
- Existing radiation therapy lacks precision for small, moving tumors.
Purpose:
- To develop a "Next-Generation Radiation Therapy System" for early-stage cancer treatment.
- To achieve sub-millimeter accuracy in targeting deep-seated tumors.
- To enhance patient quality of life and reduce healthcare expenditures.
Summary:
- A novel radiation therapy system utilizes high-energy, narrow X-ray beams for precise tumor targeting.
- The system is designed to accurately treat small, mobile tumors, overcoming limitations of current technologies.
- Performance testing of a prototype is actively being conducted.
Impact:
- Potential to significantly improve early-stage cancer treatment outcomes in Japan.
- Could lead to reduced healthcare costs associated with cancer care.
- Advances Japan's position in medical technology and innovation.
